[go: up one dir, main page]

ZA200700015B - Virtual colonoscopy with radiolabeled phospholipid ether analogs - Google Patents

Virtual colonoscopy with radiolabeled phospholipid ether analogs

Info

Publication number
ZA200700015B
ZA200700015B ZA200700015A ZA200700015A ZA200700015B ZA 200700015 B ZA200700015 B ZA 200700015B ZA 200700015 A ZA200700015 A ZA 200700015A ZA 200700015 A ZA200700015 A ZA 200700015A ZA 200700015 B ZA200700015 B ZA 200700015B
Authority
ZA
South Africa
Prior art keywords
virtual colonoscopy
phospholipid ether
ether analogs
radiolabeled phospholipid
radiolabeled
Prior art date
Application number
ZA200700015A
Other languages
English (en)
Inventor
Jamey P Weichert
Longino Marc
Original Assignee
Cellectar Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectar Llc filed Critical Cellectar Llc
Publication of ZA200700015B publication Critical patent/ZA200700015B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0408—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200700015A 2004-07-08 2007-01-02 Virtual colonoscopy with radiolabeled phospholipid ether analogs ZA200700015B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52183104P 2004-07-08 2004-07-08

Publications (1)

Publication Number Publication Date
ZA200700015B true ZA200700015B (en) 2008-09-25

Family

ID=35503411

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700015A ZA200700015B (en) 2004-07-08 2007-01-02 Virtual colonoscopy with radiolabeled phospholipid ether analogs

Country Status (14)

Country Link
US (1) US7700075B2 (xx)
EP (1) EP1773408A2 (xx)
JP (1) JP2008508909A (xx)
KR (1) KR20070054630A (xx)
CN (1) CN101001647A (xx)
AU (1) AU2005269861A1 (xx)
BR (1) BRPI0511445A (xx)
CA (1) CA2572398A1 (xx)
IL (1) IL180363A0 (xx)
MX (1) MX2007000207A (xx)
NO (1) NO20070705L (xx)
NZ (1) NZ552914A (xx)
WO (1) WO2006014589A2 (xx)
ZA (1) ZA200700015B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8540968B2 (en) 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
AU2005219412A1 (en) * 2004-03-02 2005-09-15 Cellectar, Inc. Phospholipid analogs for diagnosis and treatment of cancer
JP2008545614A (ja) * 2004-12-20 2008-12-18 セレクター、リミテッド ライアビリティ カンパニー 癌の検出および治療のためのリン脂質エーテル類似体
WO2006114658A2 (en) * 2005-04-28 2006-11-02 Yeda Research And Development Co., Ltd Lung cancer diagnosis using magnetic resonance imaging data obtained at three time points
US7414254B2 (en) * 2005-06-28 2008-08-19 United Pharmacy Partners, Inc. Tungsten pig for radio-pharmaceuticals
US20070208331A1 (en) * 2006-03-02 2007-09-06 Chu Michael S Systems and methods of treatment within a gastrointestinal lumen
EP1985713A1 (en) * 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Methods and tools for detecting the presence of colorectal adenocarcinoma cells
US20080319315A1 (en) * 2007-06-07 2008-12-25 Beth Israel Deaconess Medical Center Method of reducing interferences in positron emission tomography
WO2010011844A1 (en) * 2008-07-25 2010-01-28 Tufts Medical Center A system and method of clinical treatment planning of complex, monte carlo-based brachytherapy dose distributions
EP2429591B1 (en) 2009-05-11 2015-08-26 Cellectar, Inc. Fluorescent phospholipid ether compounds, compositions, and methods of use
US8871181B2 (en) 2009-05-11 2014-10-28 Cellectar, Inc. Fluorescent phospholipid ether compounds, compositions, and methods of use
DK3708192T3 (da) * 2009-06-12 2023-11-06 Cellectar Inc Etherphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller
JP2013504590A (ja) * 2009-09-11 2013-02-07 セレクター，インコーポレイティド 非放射性リン脂質化合物、組成物、及び使用方法
MX342405B (es) 2010-06-03 2016-09-28 Pharmacyclics Inc El uso de inhibidores de la tirosina quinasa de bruton (btk).
KR101341288B1 (ko) 2013-10-24 2013-12-12 사회복지법인 삼성생명공익재단 방사선 치료기의 품질 보증 시스템 및 그 품질 보증 방법
JP2017509336A (ja) 2014-03-20 2017-04-06 ファーマサイクリックス エルエルシー ホスホリパーゼｃガンマ２及び耐性に関連した変異
ES2978534T3 (es) 2014-11-17 2024-09-13 Cellectar Biosciences Inc Análogos de éter de fosfolípidos como vehículos de fármacos contra el cáncer
US10839509B2 (en) 2015-07-10 2020-11-17 3Scan Inc. Spatial multiplexing of histological stains
US11147823B2 (en) * 2016-07-13 2021-10-19 Wisconsin Alumni Research Foundation Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors
KR102396334B1 (ko) * 2016-07-18 2022-05-09 위스콘신 얼럼나이 리서어치 화운데이션 인 시츄 면역 조절 암 백신화를 위한 방사성할로겐화 제제
RU2755010C1 (ru) * 2021-01-26 2021-09-09 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") Способ диагностики рака ободочной кишки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925649A (en) * 1987-06-12 1990-05-15 The University Of Michigan Radioiodinated diacylglycerol analogues and methods of use
US5347030A (en) * 1987-10-23 1994-09-13 The Board Of Regents Of The University Of Michigan Radioiodinated phospholipid ether analogues and methods of using same
US5087721A (en) * 1987-10-23 1992-02-11 The University Of Michigan Radioiodinated phosphate esters
US4965391A (en) * 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US6255519B1 (en) * 1996-12-04 2001-07-03 Regents Of The University Of Michigan Radioiodinated phospholipid ether analogs and methods of using the same
AU2005219412A1 (en) * 2004-03-02 2005-09-15 Cellectar, Inc. Phospholipid analogs for diagnosis and treatment of cancer
JP2008545614A (ja) * 2004-12-20 2008-12-18 セレクター、リミテッド ライアビリティ カンパニー 癌の検出および治療のためのリン脂質エーテル類似体
CN100415584C (zh) * 2005-02-04 2008-09-03 比亚迪股份有限公司 机动车制动防抱死的控制系统和方法

Also Published As

Publication number Publication date
US20070098633A2 (en) 2007-05-03
KR20070054630A (ko) 2007-05-29
MX2007000207A (es) 2007-03-30
WO2006014589A2 (en) 2006-02-09
CN101001647A (zh) 2007-07-18
US20060013767A1 (en) 2006-01-19
NO20070705L (no) 2007-04-02
CA2572398A1 (en) 2006-02-09
EP1773408A2 (en) 2007-04-18
IL180363A0 (en) 2007-06-03
NZ552914A (en) 2009-12-24
WO2006014589A3 (en) 2006-04-20
BRPI0511445A (pt) 2007-12-26
AU2005269861A1 (en) 2006-02-09
US7700075B2 (en) 2010-04-20
JP2008508909A (ja) 2008-03-27
AU2005269861A2 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
ZA200700015B (en) Virtual colonoscopy with radiolabeled phospholipid ether analogs
ZA200700357B (en) Tetrapetide analogs
GB0424175D0 (en) Virtual computing infrastructure
GB0424126D0 (en) Virtual computing infrastructure
EP1929780A4 (en) VIRTUAL CHANNELS
GB0410551D0 (en) 3d autostereoscopic display
AU2005292743A1 (en) Improved stereoscopic display
IL209859A0 (en) Epitope analogs
EP1941485A4 (en) VIRTUAL OFFICE ENVIRONMENT
EP2002400A4 (en) EDITOR FOR VIRTUAL VIEWS
ZA200703022B (en) N-benzenesulfonyl substituted anilino-pyrimidine analogs
GB0725119D0 (en) Virtual apparel fitting
EP1713002A4 (en) VIRTUAL COMMUNITY SYSTEM
GB0720598D0 (en) Contact center integration into virtual environments
EP2095307A4 (en) USER INTERFACE FOR INTERACTIVE 3D SHORTAGE MONITORING
GB0501809D0 (en) Anti-migraine formulations
AP2007003894A0 (en) Tetrapeptide analogs
IL177964A0 (en) Glyphosate composition
GB2424891B (en) Impact-modified blends
EP1810029A4 (en) Topiramate analogs
GB0425187D0 (en) Improvements to seals
EP1849856A4 (en) CLEANING SUPPLIES
GB2425673B (en) 3D Display
GB0406939D0 (en) Improvements to lenticular display arrangement
GB0415184D0 (en) Virtual Trainer